Family nurse practitioner directed education of the primary care provider for HIV prevention utilizing pre-exposure prophylaxis
Title
Family nurse practitioner directed education of the primary care provider for HIV prevention utilizing pre-exposure prophylaxis
Creator
Weimer, Jonathan
Description
Weimer, Jonathan
The worldwide prevalence of HIV is now greater than 35 million people (TenoRes, 2016). Global incidence of HIV is now over 2 million new infections annually (Krakower & Mayer, 2015; Krakower et al, 2015; Jain et al, 2015; Aaron et al, 2016; Anzala et al, 2014; TenoRes, 2016). The MSM population represents the majority, 65%, of new cases in the United States at a rate of about 30,000 per year (Krakower et al, 2015; Jain et al, 2015; Klausner & Scott, 2016; Aaron et al, 2016). In addition to behavioral methods alone, biomedical and pharmacologic methods of reducing overall population viral loads of those currently infected with HIV, thus reducing rates of infectivity, have been another important strategy for curbing new infection rates. Pre-exposure prophylaxis, or PrEP, is a pharmacological intervention method in which an individual uninfected with HIV takes a daily anti-retro viral medications, prior to potential exposures to the HIV virus, in order to prevent HIV infection. Examining multiple benefits and barriers to PrEP uptake assists in examining ways to better disseminate PrEP and increase uptake. The project implementation plan has the potential to address many of these barriers for both patients and providers. Keywords: Pre-exposure prophylaxis (PrEP), human immunodeficiency virus (HIV), men who have sex with men (MSM), sero-discordant, stigma, post-exposure prophylaxis (PEP)
The worldwide prevalence of HIV is now greater than 35 million people (TenoRes, 2016). Global incidence of HIV is now over 2 million new infections annually (Krakower & Mayer, 2015; Krakower et al, 2015; Jain et al, 2015; Aaron et al, 2016; Anzala et al, 2014; TenoRes, 2016). The MSM population represents the majority, 65%, of new cases in the United States at a rate of about 30,000 per year (Krakower et al, 2015; Jain et al, 2015; Klausner & Scott, 2016; Aaron et al, 2016). In addition to behavioral methods alone, biomedical and pharmacologic methods of reducing overall population viral loads of those currently infected with HIV, thus reducing rates of infectivity, have been another important strategy for curbing new infection rates. Pre-exposure prophylaxis, or PrEP, is a pharmacological intervention method in which an individual uninfected with HIV takes a daily anti-retro viral medications, prior to potential exposures to the HIV virus, in order to prevent HIV infection. Examining multiple benefits and barriers to PrEP uptake assists in examining ways to better disseminate PrEP and increase uptake. The project implementation plan has the potential to address many of these barriers for both patients and providers. Keywords: Pre-exposure prophylaxis (PrEP), human immunodeficiency virus (HIV), men who have sex with men (MSM), sero-discordant, stigma, post-exposure prophylaxis (PEP)
Date
2016
Publisher
Alverno College
Extent
50 pages
Language
English
Format
PDF
Type
Text
Capstone Project
Rights
These materials may be used by individuals and libraries for personal use, research, teaching (including distribution to classes), or for any fair use as defined by U.S. Copyright Law.
Collection
Citation
Weimer, Jonathan, “Family nurse practitioner directed education of the primary care provider for HIV prevention utilizing pre-exposure prophylaxis,” Alverno College Library Digital Commons, accessed May 13, 2025, https://alverno.omeka.net/items/show/671.